| 发明名称 |
Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide |
| 摘要 |
<p>The invention relates to the therapeutic use of a second generation immunomodulatory oligonucleotide in combination with HIV-1 antigen or immunogen to enhance the ability to reduce the risk HIV infection and to control the progression of HIV infection to prevent AIDS Related Complex (ARC) and AIDS.</p> |
| 申请公布号 |
AU2005222909(B2) |
申请公布日期 |
2010.03.11 |
| 申请号 |
AU20050222909 |
申请日期 |
2005.03.11 |
| 申请人 |
THE IMMUNE RESPONSE CORPORATION;IDERA PHARMACEUTICALS, INC. |
发明人 |
RICHARD BARTHOLOMEW;SUDHIR AGRAWAL;EKAMBAR KANDIMALLA;MARIO CLERICI;DOROTHY BRAY |
| 分类号 |
A61K39/00;A61K39/21;A61K48/00 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
